Prediction of Treatment Response in Head and Neck Cancer by Magnetic Resonance Spectroscopy
Tedros Bezabeha,
Olva Odluma,b,
Richard Nasona,c,
Paul Kerra,c,
Donna Sutherlanda,c,
Rakesh Patela and
Ian C.P. Smitha
a From the Institute for Biodiagnostics, National Research Council, University of Manitoba, Canada
b Faculty of Dentistry, University of Manitoba, Canada
c CancerCare Manitoba, Winnipeg, Manitoba, Canada

View larger version (18K):
[in a new window]
|
FIG 1. 360 MHz 1H MR spectra of head and neck tumors (A) control (B) failed case. Both specimens came from oral tongue tumors. Chos, choline-containing compounds; Cr, creatines; Gln, glutamine; Glu, glutamic acid; HOD, deuteriated water; Lac, lactic acid; Leu, leucine; Lip, lipid; Tau, taurine; Val, valine. Assignments do not imply that these are the only substances contributing to a particular peak.
| |

View larger version (11K):
[in a new window]
|
FIG 2. Bar graphs of the 3.2/3.0 spectral intensity ratio (mean ± SEM). Dark shade, control; light shade, failed cases; A, tumors from all sites included; B, tumors of the tongue only.
| |

View larger version (11K):
[in a new window]
|
FIG 3. Bar graphs of the 1.3/0.9 spectral intensity ratio (mean ± SEM). Dark shade, control; light shade, failed cases; A, tumors from all sites included; B, tumors of the larynx only.
| |